Breastfeeding, first-food systems and corporate power: a case study on the market and political practices of the transnational baby food industry in Brazil.

BACKGROUND: The exploitative marketing of commercial milk formula (CMF) reduces breastfeeding, and harms child and maternal health globally. Yet forty years after the International Code of Marketing of Breast-Milk Substitutes (The Code) was adopted by WHO member states, many countries are still to fully implement its provisions into national law. Furthermore, despite The Code, worldwide CMF markets have markedly expanded. In this paper, we adopt Brazil as a case study to understand the power of the baby food industry's marketing and corporate political activity, and how this influences the country's 'first-food system' in ways that promote and sustain CMF consumption. METHODS: We used a case study design, drawing data from from documents and key informant interviews (N = 10). RESULTS: Breastfeeding rates plummeted in Brazil to a historic low in the 1970s. A resurgence in breastfeeding from the mid-1980s onwards reflected strengthening political commitment for a national policy framework and breastfeeding protection law, resulting in-turn, from collective actions by breastfeeding coalitions, advocates, and mothers. Yet more recently, improvements in breastfeeding have plateaued in Brazil, while the industry grew CMF sales in Brazil by 750% between 2006 and 20. As regulations tightened, the industry has more aggressively promoted CMF for older infants and young children, as well as specialised formulas. The baby food industry is empowered through association with powerful industry groups, and employs lobbyists with good access to policymakers. The industry has captured the pediatric profession in Brazil through its long-standing association with the Brazilian Society of Pediatrics. CONCLUSION: Brazil illustrates how the baby food industry uses marketing and political activity to promote and sustain CMF markets, to the detriment of breastfeeding. Our results demonstrate that this industry requires much greater scrutiny by regulators.

A sustainable sensitive spectrofluorimetric approach for the determination of the multipotent protein lactoferrin in different pharmaceuticals and infant milk formula: Compliance with greenness metrics.

The current study presents the first spectrofluorimetric approach for the estimation of lactoferrin, depending on the measurement of its native fluorescence at 337 nm after excitation at 230 nm, without the need for any hazardous chemicals or reagents. It was found that the fluorescence intensity versus concentration calibration plot was linear over the concentration range of 0.1-10.0 µg/mL with quantitation and detection limits of 0.082 and 0.027 µg/mL, respectively. The method was accordingly validated according to the ICH recommendations. The developed method was applied for the estimation of lactoferrin in different dosage forms, including capsules and sachets with high percent recoveries (97.84-102.53) and low %RSD values (<1.95). Lactoferrin is one of the key nutrients in milk powder and a significant nutritional fortifier. In order to assess the quality of milk powder, it is essential to rapidly and accurately quantify the lactoferrin content of the product. Therefore, the presented study was successfully applied for the selective estimation of lactoferrin in milk powder with acceptable percent recoveries (96.45-104.92) and %RSD values (≤3.607). Finally, the green profile of the method was estimated using two assessment tools: Green Analytical Procedure Index (GAPI) and Analytical GREEnness (AGREE), which demonstrated its excellent greenness.

Infant milk formula, produced by membrane filtration, promotes mucus production in the upper small intestine of young pigs.

Human breast milk promotes maturation of the infant gastrointestinal barrier, including the promotion of mucus production. In the quest to produce next generation infant milk formula (IMF), we have produced IMF by membrane filtration (MEM-IMF). With a higher quantity of native whey protein, MEM-IMF more closely mimics human breast milk than IMF produced using conventional heat treatment (HT-IMF). After a 4-week dietary intervention in young pigs, animals fed a MEM-IMF diet had a higher number of goblet cells, acidic mucus and mucin-2 in the jejunum compared to pigs fed HT-IMF (P < 0.05). In the duodenum, MEM-IMF fed pigs had increased trypsin activity in the gut lumen, increased mRNA transcript levels of claudin 1 in the mucosal scrapings and increased lactase activity in brush border membrane vesicles than those pigs fed HT-IMF (P < 0.05). In conclusion, MEM-IMF is superior to HT-IMF in the promotion of mucus production in the young gut.

Infant exposure to ochratoxin A, zearalenone, and deoxynivalenol from the consumption of milk formula and baby cereal in Chile.

Ochratoxin A (OTA), zearalenone (ZEN), and deoxynivalenol (DON) are mycotoxins whose exposure is associated with various adverse health effects, including cancer and renal disorders, estrogenic effects, and immunosuppressive and gastrointestinal disorders, respectively. Infants (<2 years) are the most vulnerable group to mycotoxins, representing a unique combination of restricted food consumption types, low body weight, lower ability to eliminate toxins, and more future years to accumulate toxins. This study aimed to estimate the infant́s exposure to OTA, DON, and ZEN due to the consumption of milk formula and baby cereals in Chile. Milk formula samples (n = 41) and baby cereals (n = 30) were collected and analyzed using commercial ELISA kits for OTA, DON, and ZEA determination. Exposure was assessed by the Estimated Daily Intake (EDI) approach (mean and worst-case scenario, WCS) with the levels found in a modified Lower Bound (mLB) and Upper Bound (UB); ideal consumption (<6m, 7-12 m, and 13-24 m); adjusted by the weight of each group. The risk was estimated by comparing the EDI with a reference tolerable daily intake or by the margin of exposure (MOE) in the case of OTA. DON and OTA occurrence in infant formula were 34 % and 41 %, respectively. The co-occurrence between these mycotoxins was 22 %. Mycotoxin contents were below LOQ values except for OTA determined in one sample (0.29 ng/ml). No milk formulae were contaminated with ZEN. In the case of baby cereals, the occurrences were 17 % for OTA, 30 % for DON, and 7 % for ZEN, all below LOQ. Co-occurrence was seen in two samples between ZEN and OTA. According to exposure calculations, the MOE for OTA was less than 10,000 in all models for milk formula between 0 to 12 months of age and in the UB and WCS for cereal consumption. Health concerns were observed for DON in the WCS and UB for milk consumption in all ages and only in the UB WCS for cereal consumption. Considering the high consumption of milk formula in these age groups, regulation of OTA and other co-occurring mycotoxins in infant milk and food is strongly suggested.

High-calorie, whole protein/peptide nutritional formulations for children with cerebral palsy: a retrospective clinical study.

BACKGROUND: Children with cerebral palsy often experience inadequate nutritional intake due to factors like anorexia, intellectual impairments, underdeveloped motor skills of the oral sensory system, and eating and swallowing disorders. These challenges not only hinder their rehabilitation but also impose various degrees of burden on society and their families. Addressing malnutrition in children with cerebral palsy has become a pressing international clinical issue. This study assessed the nutritional status of children with cerebral palsy and examined the impact of a high-calorie enteral nutrition formula as a nutritional intervention. METHODS: This retrospective study involved 132 malnourished children with cerebral palsy undergoing rehabilitation at the First People's Hospital of Yulin City from July 2020 to July 2023. Sixty-six children received conventional nutritional interventions after their parents were educated and trained in dietary practices and feeding techniques, forming the general group. The other sixty-six children were given a high-calorie intact protein or short peptide enteral nutrition formula milk powder (Nuiren JUNIOR or Peptamen Junior), and were referred to as the nutrient group. Data on anthropometric measurements, blood indicators, gross motor function, and adverse events were collected at baseline, three months, and six months. RESULTS: After 6 months of intervention, both groups showed improvements in height, weight, weight-for-height Z-score, weight-for-age Z-score and gross motor function. There were statistical differences in height change, body mass index-for-age Z-score, and gross motor function between the two groups (P<0.05). The efficiency of nutritional intervention was significantly higher in the nutrient group than in the general group (P<0.05). In addition, total albumin, albumin, prealbumin, and 25-hydroxyvitamin D levels were higher in the nutrient group than in the general group (P<0.05). An incidence of side effects was observed in 15.15% of the children in the general group and 9.09% in the nutrient group, without significant difference (χ2=1.138, P=0.286). CONCLUSION: High-calorie whole protein or peptide nutritional formulas can significantly improve malnutrition and enhance gross motor function development in children with cerebral palsy and has a low incidence of adverse events. These interventions hold promise for broader clinical application.

Continuous cow's milk protein ingestion during infancy may promote casein-specific IgG4 production.

Background: Early supplementation and subsequent discontinuation of cow's milk formula (CMF) may increase the risk of cow's milk allergy in breast-fed infants, but little is known about the relationship between continuous CMF ingestion and cow's milk protein-specific immunoglobulin production. Objective: This study aimed to clarify the aforesaid relationship in cow's milk-sensitized infants. Methods: Using data from a randomized controlled trial of a Japanese birth cohort, we performed a subgroup analysis of participants who had ingested CMF in the first 3 days of life and exhibited a positive skin prick test response to cow's milk at age 6 months. We compared the differences in median titers of cow's milk-specific IgE, casein-specific IgE, and casein-specific IgG4 levels between participants who continued daily or intermittent CMF ingestion up to age 6 months (the "continuous group") and participants who discontinued CMF ingestion before age 6 months (the "discontinued group"). Results: From among 462 trial participants, 49 (10.6%) were included in this study (21 in the continuous group and 29 in the discontinued group). The median titer of cow's milk-specific IgE was 0.17 kUA/L (interquartile range [IQR] = <0.10 to 0.57) in the continuous group and 0.66 kUA/L (IQR = 0.49-1.18) in the discontinued group (P = .0008). The median titer of casein-specific IgE was <0.10 kUA/L (IQR = <0.10 to 0.15) in the continuous group and <0.10 kUA/L (IQR = <0.10 to 0.37) in the discontinued group (P = .51). The median titer of casein-specific IgG4 was 2.58 mgA/L (IQR = 0.77-6.73) in the continuous group and 0.09 mgA/L (IQR = 0.07-0.13) in the discontinued group (P < .0001). Conclusion: Continuous CMF ingestion may promote casein-specific IgG4 production in cow's milk-sensitized infants.

Estimating carbon and water footprints associated with commercial milk formula production and use: development and implications of the Green Feeding Climate Action Tool.

Carbon offset frameworks like the UN Clean Development Mechanism (CDM) have largely overlooked interventions involving food, health, and care systems, including breastfeeding. The innovative Green Feeding Climate Action Tool (GFT) assesses the environmental impact of commercial milk formula (CMF) use, and advocates for breastfeeding support interventions as legitimate carbon offsets. This paper provides an overview of the GFT's development, key features, and potential uses. The offline and online GFT were developed using the DMADV methodology (Define, Measure, Analyze, Design, Verify). The GFT reveals that the production and use of CMF by infants under 6 months results in annual global greenhouse gas (GHG) emissions of between 5.9 and 7.5 billion kg CO2 eq. and consumes 2,562.5 billion liters of water. As a national example, in India, one of the world's most populous countries, CMF consumption requires 250.6 billion liters of water and results in GHG emissions ranging from 579 to 737 million kg CO2 eq. annually, despite the country's high breastfeeding prevalence among infants under 6 months. The GFT mainly draws on data for low- and middle-income countries (LMICs), as many high-income countries (HICs) do not collect suitable data for such calculations. Despite poor official data on breastfeeding practices in HICs, GFT users can input their own data from smaller-scale surveys or their best estimates. The GFT also offers the capability to estimate and compare baseline with counterfactual scenarios, such as for interventions or policy changes that improve breastfeeding practices. In conclusion, the GFT is an important innovation to quantify CMF's environmental impact and highlight the significance of breastfeeding for planetary as well as human health. Women's contributions to environmental preservation through breastfeeding should be recognized, and breastfeeding interventions and policies should be funded as legitimate carbon offsets. The GFT quantifies CMF's carbon and water footprints and facilitates financing breastfeeding support as a carbon offset initiative under CDM funding facilities.

Investigation of the effect of breast milk, probiotic supplemented and plain milk formulas on some oral bacteria in infants: an observational and in-vitro study / Investigação do efeito do leite materno, fórmulas de leite puro e suplementado com probióticos sobre algumas bactérias orais em lactentes: um estudo observacional e in vitro

Objetivo: existem evidências inconclusivas sobre a potencial carogenicidade das fórmulas lácteas em comparação com o leite materno. O estudo teve como objetivo comparar a detecção e contagem de Streptococcus mutans(S. mutans) e lactobacilos da saliva entre lactentes alimentados com leite materno (B), com fórmulas de leite puro (France Lait-FL) e suplementada com probióticos (Nan 1 optipro-N), e avaliar crescimento in vitro dessas bactérias em amostras de leite materno e fórmulas lácteas. Material e Métodos: amostras salivares foram obtidas com swabs de algodão estéreis de 60 lactentes que foram agrupados de acordo com o tipo de leite. As amostras foram cultivadas para obter a frequência de detecção e contagens bacterianas. Para a investigação in vitro, sete amostras de leite materno doado e sete amostras recém-preparadas de ambas as fórmulas lácteas foram inoculadas por ambas as bactérias e então cultivadas para avaliar o crescimento bacteriano. Resultados:lactobacilos foram detectados em todos os lactentes, enquanto não foram encontradas diferenças significativas na detecção de S. mutans entre os grupos. As contagens de ambos os microrganismos na saliva foram menores em (B), enquanto uma diferença insignificante foi encontrada entre (B) e (N). Diferenças significativas foram evidentes nas contagens bacterianas in vitro sendo mais baixas em (B) seguido por (N) e (FL). Conclusão: o leite materno e as fórmulas lácteas com suplementos probióticos podem ter um papel protetor contra a cárie dentária em lactentes. (AU)

Objective: inconclusive evidence exists regarding potential cariogenicity of milk formulas compared to breast milk. The study aimed to compare Salivary Streptococcus mutans (S. mutans) and lactobacilli detection and counts among breastfed (B), plain formula (France Lait 1) (FL) and probiotic supplemented formula (Nan 1 optipro) (N) infants and to assess in-vitro growth of these bacteria in breast milk and milk formula samples. Material and Methods:salivary samples were obtained using sterile cotton swabs from 60 infants that were grouped according to nursing milk type. Samples were cultured to obtain the detection frequency and bacterial counts. For the in-vitro investigation, seven donated breast milk samples and seven freshly prepared samples of both milk formulas were inoculated by both bacteria and then cultured to assess bacterial growth. Results:lactobacilli were detected in all infants, while no significant differences were found in S. mutans detection among groups. Counts of both microorganisms in saliva were lowest in (B) while, insignificant difference was found between (B) and (N). Significant differences were evident in in-vitro bacterial counts being lowest in (B) followed by (N) and (FL). Conclusion: breast milk and probiotic supplement infants' milk formulas may have a protective role against dental caries in infants.(AU)

Obesidad en lactantes: efecto protector de la lactancia materna versus fórmulas lácteas / Childhood obesity: the benefits of breastfeeding versus formula feeding

El objetivo del trabajo fue analizar el posible efecto protector de la lactancia materna respecto a la obesidad infantil versus fórmulas lácteas. Se consultaron las bases de datos PubMed, Web of Science y Scielo, considerándose los artículos más actualizados sobre el tema. La evidencia analizada señala que los menores alimentados con lactancia materna exclusiva reportan bajos niveles de sobrepeso y obesidad, a diferencia de los alimentados con fórmulas lácteas infantiles. Se concluye que la lactancia materna exclusiva, hasta el sexto mes de vida del lactante, y complementada con alimentación solida (no láctea) hasta los dos o más años, es recomendada y podría proteger contra la obesidad infantil y sus comorbilidades asociadas en la vida adulta.

The aim was to review the evidence supporting the possible health benefits for obesity of breastfeeding versus formula feeding in infants. The search for studies addressing this topic was conducted in PubMed, Web of Science and Scielo databases. "Breastfeeding", "formula feeding" and "obesity" were the keywords used in the search. Only studies with a full version of the manuscript were included. The evidence analyzed indicated that children fed exclusively through breastfeeding reported low levels of overweight and obesity in comparison to those fed by infant milk formulas. To conclude, exclusive breastfeeding until the sixth month of life, and supplementation with solid (non-dairy) food until two years and more, is the gold standard and could protect against childhood obesity and its associated comorbidities in adult life.

The clinical characteristics and related factors of cow's milk protein allergy in infants less than 3 months old in Guangxi District / 中国小儿急救医学

Objective To study the clinical characteristics and risk factors of cow's milk protein allergy(CMPA)in infants less than 3 months old in Guangxi District.Methods From July 1 ,2012,to December 30,2014,infants less than 3 months old suspected of CMPA visiting the pediatric outpatient depart-ment of Maternal and Children Hospital of Guangxi Zhuang Autonomous Region were recruited,which included initial diagnosis and being transported from peripheral hospitals.Observation scale was formulated, attending physician screened patients and their senior made a definite diagnosis.All the infants underwent diagnostic algorithms and were followed up constantly.Results A total of 137 cases were divided into aller-gy group(n =51 )and control group(n =86).Two groups shared some common symptoms such as diarrhea, constipation,bloody stool,stomachache,gastroesophageal reflux(GER),indigestion,anorexia,feeding diffi-culties.Between the allergy group and control group the parameters such as feeding patterns (including breast feeding,mix feeding,formula feeding),improper deeding of food supplement,long-term use of antibiotics in neonatal period and parental atopy showed no significant differences(P ﹥0.05).The parameters in neonatal period including GER [20 cases (39.2%)vs.7 cases (8.1 %)],intake of cow's milk formula [51 cases (100%)vs.71 cases (82.6%)],feeding intolerance (including GER)[17 cases (33.3%)vs.1 1 cases (12.8%)],gut infection[8 cases(15.7%)vs.4 cases(4.7%)],transfusion of blood or/and bloody prod-ucts[12 cases(23.5%)vs.1 1 cases(12.8%)]showed statistically significant differences between the aller-gy group and control group(χ2 =19.538,P =0.000;χ2 =9.989,P =0.002;χ2 =8.308,P =0.004;χ2 =4.691 ,P =0.030;χ2 =5.198,P =0.023 ).Conclusion Symptoms of CMPA in infants no more than 3 months old involve mainly digestive system such as diarrhea,bloody stool,GER.Intake of cow milk formula in neonatal period play an important role in triggering CMPA.

Occurrence and characterization of toxigenic Bacillus cereus in food and infant feces

Objective:To investigate the true incidence of Bacillus cereus (B. cereus) in food and children diarrhea cases. Methods:A total of 110 samples of various dairy products such as raw milk, long life pasteurized milk, yoghurt and infant powdered milk formulas, raw rice, and feces were examined for the presence of B. cereus by selective plating on mannitol-egg-yolk-polymyxin agar. Confirmation of B. cereus was carried out by biochemical tests and PCR. Identification of non-B. cereus isolates was carried out by 16S rDNA sequencing. Antimicrobial susceptibility was done by disk diffusion method. Results:Overall 35 samples (31.8%, n=110) yielded Bacillus-like growth. Of which 19 samples (54.28%) were positive for B. cereus. All isolates were positive for enterotoxin production. No psychrotolerant B. cereus strains were detected in all samples. All B. cereus isolates were resistant to penicillin G, but susceptible to vancomycin, erythromycin and clindamycin. Conclusions:The results of this study confirm the importance of including B. cereus in disease control and prevention programs, as well as in routine clinical and food quality control laboratories in both Saudi Arabia and Egypt.

Occurrence and characterization of toxigenic Bacillus cereus in food and infant feces

Objective: To investigate the true incidence of Bacillus cereus (B. cereus) in food and children diarrhea cases. Methods: A total of 110 samples of various dairy products such as raw milk, long life pasteurized milk, yoghurt and infant powdered milk formulas, raw rice, and feces were examined for the presence of B. cereus by selective plating on mannitol-egg-yolkpolymyxin agar. Confirmation of B. cereus was carried out by biochemical tests and PCR. Identification of non-B. cereus isolates was carried out by 16S rDNA sequencing. Antimicrobial susceptibility was done by disk diffusion method. Results: Overall 35 samples (31.8%, n = 110) yielded Bacillus-like growth. Of which 19 samples (54.28%) were positive for B. cereus. All isolates were positive for enterotoxin production. No psychrotolerant B. cereus strains were detected in all samples. All B. cereus isolates were resistant to penicillin G, but susceptible to vancomycin, erythromycin and clindamycin. Conclusions: The results of this study confirm the importance of including B. cereus in disease control and prevention programs, as well as in routine clinical and food quality control laboratories in both Saudi Arabia and Egypt.

Perfil de triacilgliceroles y porcentaje de ácido palmítico en la posición sn-2 en sustitutos de leche materna / Profile of triacylglycerols and percentage of palmitic acid at the sn-2 in breast milk substitutes

El objetivo del presente trabajo es analizar el porcentaje de ácido palmítico en la posición sn-2 de los triacilgliceroles en sustitutos de la leche materna. Se analizaron 6 productos del mercado argentino que se presentan como sustitutos de la leche materna durante el primer semestre de vida: 2 fórmulas con aceites vegetales como fuente básica de lípidos (F1 y F2); 1 fórmula con grasa láctea como base y aceites vegetales (F3); 1 fórmula con lípidos estructurados y aceites vegetales (F4); 2 fórmulas para prematuros, una con grasa láctea como base y otros aceites (F5) y otra con aceites vegetales (F6). Los resultados muestran que F1, F2, F3 y F4 presentaron 14,6%, 14,8%, 48,1% y 44,5% del ácido palmítico en la posición sn-2, respectivamente. Por su parte, las fórmulas F5 y F6 presentaron 49,5% y 14,6% delácido palmítico en la posición sn-2. Las fórmulas con base láctea presentaron la mayor concentración de ácido palmítico en la posición sn-2.

The aim of this study was to analyze the percentage of palmitic acid at sn-2 position on triacylglycerols in infant formulas. We studied 6 infant formulas in the Argentinean market that are used as breast-milk substitutes during the frst six months after delivery: 2 formulas with vegetable oils as basic source of lipids (F1, F2); 1 formula with milk fat and vegetable oils (F3); 1 formula with structured lipids and vegetable oils (F4); 2 formulas for pre-term infants, one with milk fat and other oils (F5), and the other with vegetable oils (F6). Results showed that F1, F2, F3 and F4 presented 14.6%, 14.8%, 48.1% and 44.5%, respectively, of palmitic acid at sn-2 position, whereas formulas F5 and F6 had 49.5% and 14.6%, respectively, of palmitic acid at sn-2 position. Milk-based infant formulas had the highest concentration of palmitic acid at sn-2 position.

Perfil de triacilgliceroles y porcentaje de ácido palmítico en la posición sn-2 en sustitutos de leche materna / Profile of triacylglycerols and percentage of palmitic acid at the sn-2 in breast milk substitutes

El objetivo del presente trabajo es analizar el porcentaje de ácido palmítico en la posición sn-2 de los triacilgliceroles en sustitutos de la leche materna. Se analizaron 6 productos del mercado argentino que se presentan como sustitutos de la leche materna durante el primer semestre de vida: 2 fórmulas con aceites vegetales como fuente básica de lípidos (F1 y F2); 1 fórmula con grasa láctea como base y aceites vegetales (F3); 1 fórmula con lípidos estructurados y aceites vegetales (F4); 2 fórmulas para prematuros, una con grasa láctea como base y otros aceites (F5) y otra con aceites vegetales (F6). Los resultados muestran que F1, F2, F3 y F4 presentaron 14,6%, 14,8%, 48,1% y 44,5% del ácido palmítico en la posición sn-2, respectivamente. Por su parte, las fórmulas F5 y F6 presentaron 49,5% y 14,6% delácido palmítico en la posición sn-2. Las fórmulas con base láctea presentaron la mayor concentración de ácido palmítico en la posición sn-2.(AU)

The aim of this study was to analyze the percentage of palmitic acid at sn-2 position on triacylglycerols in infant formulas. We studied 6 infant formulas in the Argentinean market that are used as breast-milk substitutes during the frst six months after delivery: 2 formulas with vegetable oils as basic source of lipids (F1, F2); 1 formula with milk fat and vegetable oils (F3); 1 formula with structured lipids and vegetable oils (F4); 2 formulas for pre-term infants, one with milk fat and other oils (F5), and the other with vegetable oils (F6). Results showed that F1, F2, F3 and F4 presented 14.6%, 14.8%, 48.1% and 44.5%, respectively, of palmitic acid at sn-2 position, whereas formulas F5 and F6 had 49.5% and 14.6%, respectively, of palmitic acid at sn-2 position. Milk-based infant formulas had the highest concentration of palmitic acid at sn-2 position.(AU)

Perfil de triacilgliceroles y porcentaje de ácido palmítico en la posición sn-2 en sustitutos de leche materna / Profile of triacylglycerols and percentage of palmitic acid at the sn-2 in breast milk substitutes

El objetivo del presente trabajo es analizar el porcentaje de ácido palmítico en la posición sn-2 de los triacilgliceroles en sustitutos de la leche materna. Se analizaron 6 productos del mercado argentino que se presentan como sustitutos de la leche materna durante el primer semestre de vida: 2 fórmulas con aceites vegetales como fuente básica de lípidos (F1 y F2); 1 fórmula con grasa láctea como base y aceites vegetales (F3); 1 fórmula con lípidos estructurados y aceites vegetales (F4); 2 fórmulas para prematuros, una con grasa láctea como base y otros aceites (F5) y otra con aceites vegetales (F6). Los resultados muestran que F1, F2, F3 y F4 presentaron 14,6%, 14,8%, 48,1% y 44,5% del ácido palmítico en la posición sn-2, respectivamente. Por su parte, las fórmulas F5 y F6 presentaron 49,5% y 14,6% delácido palmítico en la posición sn-2. Las fórmulas con base láctea presentaron la mayor concentración de ácido palmítico en la posición sn-2.(AU)

The aim of this study was to analyze the percentage of palmitic acid at sn-2 position on triacylglycerols in infant formulas. We studied 6 infant formulas in the Argentinean market that are used as breast-milk substitutes during the frst six months after delivery: 2 formulas with vegetable oils as basic source of lipids (F1, F2); 1 formula with milk fat and vegetable oils (F3); 1 formula with structured lipids and vegetable oils (F4); 2 formulas for pre-term infants, one with milk fat and other oils (F5), and the other with vegetable oils (F6). Results showed that F1, F2, F3 and F4 presented 14.6%, 14.8%, 48.1% and 44.5%, respectively, of palmitic acid at sn-2 position, whereas formulas F5 and F6 had 49.5% and 14.6%, respectively, of palmitic acid at sn-2 position. Milk-based infant formulas had the highest concentration of palmitic acid at sn-2 position.(AU)

¿Cuál es el impacto de incorporar probióticos a la leche de fórmula en la salud de lactantes y niños no prematuros?: síntesis rápida de evidencia / What is the impact of incorporating probiotics into formula milk on the health of infants and non premature infants?: rapid evidence synthesis

ANTECEDENTES Y OBJETIVO Dada la amplia diversidad existente de probióticos y las distintas formas y dosis de administración, es esencial conocer en detalle evidencia científica disponible con el objetivo de determinar con claridad los beneficios sanitarios y los potenciales efectos adversos que su administración pudiese generar en la población. En este contexto el Departamento de Nutrición y Alimentos/DIPOL solicitan esta síntesis de evidencia con el objetivo de describir los principales resultados científicos relativos al efecto clínico de la suplementación alimentaria con probióticos, en lactantes y niños no prematuros. METODOLOGÍA Se formuló una estrategia de búsqueda para ser utilizada en 5 bases de datos con el objetivo de identificar revisiones sistemáticas del tema. Se seleccionaron preferentemente las que se realizaron en los últimos 5 años y que abordaban específicamente el impacto directo en la leche de fórmula sobre niños no prematuros. Se incluyeron artículos que consideraban la ingesta de probióticos en general, mientras que se excluyeron los que no tenían como población objetivo a niños o lactantes. RESULTADOS El resumen utiliza 13 revisiones sistemáticas -El uso de probióticos sería beneficioso para el tratamiento y prevención de enfermedades gastrointestinales en infantes y niños, no obstante, no es claro su impacto sobre algunas de estas enfermedades. -Los probióticos tiene un efecto beneficioso en la frecuencia y duración de infecciones agudas respiratorias altas en niños. Sin embargo, los resultados presentan alta heterogeneidad. -La suplementación de la alimentación con probióticos produce una disminución de la incidencia y gravedad de la dermatitis atópica en niños. La evidencia en la prevención de otras enfermedades alérgicas no es clara. -No está claro si hay un efecto significativo en el crecimiento de infantes alimentados con leche de formula suplementada con probióticos. -La escasa evidencia disponible muestra que la suplementación de la alimentación con probióticos no produciría efectos adversos. -Pese al posible efecto que pudiese tener el financiamiento por parte de la industria en la calidad metodológica y efecto clínico de los ensayos clínicos controlados, no existiría una asociación significativa de sesgo de resultados en comparación con estudios financiados con otro tipo de fuentes.